These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 1246375)

  • 21. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The potency of the progestational agents in oral contraceptives (author's transl)].
    Rindt W
    Geburtshilfe Frauenheilkd; 1973 Aug; 33(8):640-46. PubMed ID: 4747151
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of contraceptive hormone preparations on the fine structure of the endometrium.
    Friedrich ER
    Obstet Gynecol; 1967 Aug; 30(2):201-19. PubMed ID: 4143586
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
    Whitehead MI; Townsend PT; Pryse-Davies J; Ryder TA; King RJ
    N Engl J Med; 1981 Dec; 305(27):1599-605. PubMed ID: 7312007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experience with two low dosage estrogen progestogen preparations (SH 7.1122 and SH B 259 AB)].
    Leone U; Di Girolamo V
    Minerva Ginecol; 1980 Sep; 32(9):791-800. PubMed ID: 7012684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and misuse of the term potency with respect to oral contraceptives.
    Goldzieher JW
    J Reprod Med; 1986 Jun; 31(6 Suppl):533-9. PubMed ID: 3723485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potencies of oral contraceptives.
    Edgren RA; Sturtevant FM
    Am J Obstet Gynecol; 1976 Aug; 125(8):1029-38. PubMed ID: 952300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of the endometrium during oral hormonal contraception with ethinyl estradiol sulfonate and norethisterone acetate or d-noregestrel].
    Büttner HH; Göretzlehner G; Rudolf K
    Zentralbl Gynakol; 1976; 98(15):914-8. PubMed ID: 970000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrinological studies with desogestrel.
    van der Vies J; de Visser J
    Arzneimittelforschung; 1983; 33(2):231-6. PubMed ID: 6221730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects, on the endometrium, of a new oral contraceptive: Physiostat].
    Delacroix P
    Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717
    [No Abstract]   [Full Text] [Related]  

  • 32. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM; Zhang HF; Barnowski C; Wan GJ
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
    Varma TR
    Acta Obstet Gynecol Scand; 1985; 64(1):41-6. PubMed ID: 2983513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clinical use of me-quingestanol contraceptive pill (author's transl)].
    Zhonghua Fu Chan Ke Za Zhi; 1979 Apr; 14(2):68-72. PubMed ID: 263035
    [No Abstract]   [Full Text] [Related]  

  • 38. Preliminary experience with a 'sub-50' combined oral contraceptive, containing 35 micrograms ethinyl oestradiol and 1 mg norethisterone ('NeoCon').
    Schellen AM
    Pharmatherapeutica; 1980; 2(6):412-5. PubMed ID: 7433480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
    Ellis J
    Clin Ther; 1986; 8(6):607-18. PubMed ID: 3539347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collaborative study of an assay for progestational steroids in individual contraceptive tablets.
    Wu JY
    J Assoc Off Anal Chem; 1977 Jul; 60(4):922-5. PubMed ID: 893310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.